Skip to content
ClinCalc Pro
Menu
5-HT₁A partial agonist (anxiolytic)

Buspirone hydrochloride

Brand names: Buspar (legacy)

Buspirone is a non-benzodiazepine anxiolytic used for the short-term management of generalised anxiety disorder.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is a partial agonist at 5-HT1A serotonin receptors, modulating serotonergic neurotransmission to produce anxiolysis without significant sedative, muscle-relaxant or dependence-forming effects.

Prescribing in practice

  • Its anxiolytic effect develops gradually over weeks, so it is unsuitable for acute anxiety or 'as required' relief and patients should be told not to expect an immediate benefit.
  • It does not prevent or treat benzodiazepine withdrawal, so a patient being switched from a benzodiazepine still needs that drug tapered separately.
  • Avoid concurrent monoamine oxidase inhibitors and use caution with other serotonergic agents because of the risk of hypertensive or serotonergic reactions.

Monitoring

Monitor anxiety symptom response and tolerability over the first few weeks of treatment.

Counselling the patient

  • This medicine takes a couple of weeks to start working, so keep taking it regularly rather than only when anxious.
  • Avoid grapefruit juice, which can raise the amount of drug in your body.
  • Report severe headache or feeling very agitated.

Evidence & guidelines

Buspirone is an established option for generalised anxiety disorder, distinct from benzodiazepines in lacking dependence liability.

Reference: NICE NG191; NICE CG113; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.